Trial Information
Association of NFKB1 -94 Polymorphism With Lung and/or Kidney Injury After Cardiac Surgery With Cardiopulmonary Bypass
Inclusion Criteria:
- Chinese Han unrelated population
- undergoing elective cardiac surgery with CPB
Exclusion Criteria:
- malignant tumor
- autoimmune disease, immunodeficiency or immunosuppressive therapy
- chronic renal disease (glomerular filtration rate < 60ml/(min•1.73m2)) or liver
dysfunction (Child Pugh classification>A)
- COPD, tuberculosis or other chronic pulmonary diseases
- anemia with hemoglobin lower than 90mmHg
- bleeding disorders
- postoperative pericardial tamponade requiring re-operation
- postoperative low cardiac output syndrome or acute pulmonary edema after left cardiac
failure.
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Outcome Measure:
lung injury and/or kidney injury after cardiac surgery with cardiopulmonary bypass
Outcome Time Frame:
24h after cardiac surgery
Safety Issue:
Yes
Authority:
China: Ethics Committee
Study ID:
PCSP-NFKB1
NCT ID:
NCT00819871
Start Date:
May 2008
Completion Date:
December 2008
Related Keywords:
- Single Nucleotide Polymorphism
- Acute Lung Injury
- Kidney Injury
- Acute Lung Injury
- Respiratory Distress Syndrome, Adult
- Lung Injury